MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,000 | -28.6% | 12,400 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +133.3% | 12,400 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 12,400 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -33.3% | 12,400 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -64.0% | 12,400 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | -97.7% | 12,400 | -96.8% | 0.00% | – |
| Q1 2019 | $1,069,000 | -2.2% | 383,297 | +6.2% | 0.00% | – |
| Q4 2018 | $1,093,000 | -47.5% | 360,766 | -3.2% | 0.00% | – |
| Q3 2018 | $2,081,000 | +6.3% | 372,647 | +21.9% | 0.00% | – |
| Q2 2018 | $1,958,000 | +67.8% | 305,768 | +84.0% | 0.00% | – |
| Q1 2018 | $1,167,000 | -26.5% | 166,145 | +9.0% | 0.00% | – |
| Q4 2017 | $1,587,000 | +49.7% | 152,383 | +31.5% | 0.00% | – |
| Q3 2017 | $1,060,000 | -22.7% | 115,921 | +9.3% | 0.00% | – |
| Q2 2017 | $1,372,000 | – | 106,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,200,000 | $7,692,000 | 1.99% |
| BIEGEL & WALLER LLC | 66,508 | $426,000 | 0.26% |
| 683 Capital Management, LLC | 500,000 | $3,205,000 | 0.22% |
| Artal Group S.A. | 500,000 | $3,205,000 | 0.07% |
| BSW Wealth Partners | 22,236 | $143,000 | 0.06% |
| Aveo Capital Partners, LLC | 16,732 | $107,000 | 0.05% |
| ATLAS CAPITAL ADVISORS LLC | 12,891 | $92,300,000 | 0.03% |
| Radnor Capital Management, LLC | 10,000 | $64,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 173,686 | $1,113,000 | 0.02% |
| Engineers Gate Manager LP | 16,565 | $106,000 | 0.01% |